Sebastian Wolf, Allergan (C), Bayer (C), Bayer (S), Boehringer-Ingelheim (C), Chengdu Kanghong Biotech (C), Heidelberg Engineering (F), Heidelberg Engineering (C), Novartis (C), Oxurion (C), Roche (C), Zeiss (C);
Frank Holz, Acucela (F), Acucela (C), Apellis Pharmaceuticals (F), Apellis Pharmaceuticals (C), Bayer (F), Bayer (C), Bioeq/Formycon AG (F), Bioeq/Formycon AG (C), Boehringer-Ingelheim (C), CenterVue (F), Chengdu Kanghong Pharmaceuticals (F), Chengdu Kanghong Pharmaceuticals (C), Geuder AG (C), Graybug Vision (C), Heidelberg Engineering (F), Heidelberg Engineering (C), Lin Bioscience (C), NightstaRx (F), Novartis (F), Novartis (C), Optos (F), Pixium Vision (F), Roche/Genentech (F), Roche/Genentech (C), Zeiss Pharma (F);
Philip Hykin, Allergan (C), Allergan (R), Bayer (S), Bayer HealthCare (C), Bayer HealthCare (R), Novartis (C), Novartis (R);
Edoardo Midena, Bayer (S);
Eric Souied, Bayer (S);
George Lambrou, Bayer (E);
Tobias Machewitz, Bayer (E);
Helmut Allmeier, Bayer (E);
Paul Mitchell, Allergan (C), Bayer (C), Bayer (S), Novartis (C)